Baynes Roy D.
- SEC CIK
- 0001680739
In the past year, 6 open-market sale filings worth $5.36M and no purchases.
Current role at each company
- AARD Aardvark Therapeutics, Inc.Directoras of Aug 21, 2026
- NTRA Natera, Inc.Directoras of Jun 30, 2026
- TVTX Travere Therapeutics, Inc.Directoras of Jun 16, 2026
- NRIX Nurix Therapeutics, Inc.Directoras of May 15, 2026
- EIKN Eikon Therapeutics, Inc.Chief Medical Officeras of Mar 4, 2026
Show 1 more company
- ATRA Atara Biotherapeutics, Inc.Directoras of Jun 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.36M
- 6 filings
- Net
- −$5.36M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Baynes Roy D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TVTX Travere Therapeutics, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 (view filing) | Jun 12 | 4 days | Baynes Roy D.Director | SSale | −4.50K | $50.00 | −$225.0K | −9.8%41.5K after | 10b5-1 |
| May 6, 2026 (view filing) | May 5 | 1 day | Baynes Roy D.Director | SSale | −4.50K | $46.65 | −$209.9K | −10.7%37.5K after | 10b5-1 |
| May 4, 2026 (view filing) | May 1 | 3 days | Baynes Roy D.Director | SSale | −9.75K | $44.22 | −$431.1K | −20.6%37.5K after | 10b5-1 |
| Apr 16, 2026 (view filing) | Apr 14 | 2 days | Baynes Roy D.Director | SSale | −32.8K | $41.29 | −$1.35M | −46.6%37.5K after | 2 lots10b5-1 |
| Apr 7, 2026 (view filing) | Apr 6 | 1 day | Baynes Roy D.Director | SSale | −10.0K | $33.00 | −$330.0K | −21.1%37.5K after | 10b5-1 |
| Feb 10, 2025 (view filing) | Feb 6 | 4 days | Baynes Roy D.Director | SSale | −10.0K | $22.00 | −$220.0K | −24.4%31.0K after | 10b5-1 |
| Jan 23, 2025 (view filing) | Jan 23 | Same day | Baynes Roy D.Director | SSale | −16.0K | $20.00 | −$320.0K | −34.0%31.0K after | 10b5-1 |
NTRA Natera, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 (view filing) | Nov 19-20 | 2 days | Baynes Roy D.Director | SSale | −12.8K | $219.85 | −$2.81M | −41.0%18.4K after | 8 lots10b5-1 |
| Nov 15, 2024 (view filing) | Nov 15 | Same day | Baynes Roy D.Director | SSale | −37.2K | $146.11 | −$5.44M | −70.2%15.8K after | 6 lots10b5-1 |